{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:46:39Z","timestamp":1788324399847,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07389-9","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:25:59Z","timestamp":1760523959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Observed improvements in immune parameters and behavioral symptoms following low-dose IL-2 treatment in four autistic children with immune dysfunction"],"prefix":"10.1186","volume":"25","author":[{"given":"Huiling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuqing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"7389_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-clinpsy-032813-153710","volume":"10","author":"FR Volkmar","year":"2014","unstructured":"Volkmar FR, McPartland JC. From Kanner to DSM-5: autism as an evolving diagnostic concept. ANNU REV CLIN PSYCHO. 2014;10:193\u2013212.","journal-title":"ANNU REV CLIN PSYCHO"},{"issue":"9920","key":"7389_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai MC, Lombardo MV, Baron-Cohen S. Autism LANCET. 2014;383(9920):896\u2013910.","journal-title":"Autism LANCET"},{"issue":"2","key":"7389_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","volume":"72","author":"MJ Maenner","year":"2023","unstructured":"Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzgerald RT, Furnier SM, Hughes MM, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 Years - autism and developmental disabilities monitoring network, 11 sites, united states, 2020. MMWR SURVEILL SUMM. 2023;72(2):1\u201314.","journal-title":"MMWR SURVEILL SUMM"},{"issue":"2","key":"7389_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota T, King BH. Autism spectrum disorder: A review. JAMA-J AM MED ASSOC. 2023;329(2):157\u201368.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"6","key":"7389_CR5","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","volume":"54","author":"SF Ahmad","year":"2017","unstructured":"Ahmad SF, Zoheir K, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alzahrani MZ, Al-Shabanah OA, Al-Harbi MM, Attia SM. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. MOL NEUROBIOL. 2017;54(6):4390\u2013400.","journal-title":"MOL NEUROBIOL"},{"key":"7389_CR6","doi-asserted-by":"publisher","first-page":"732611","DOI":"10.3389\/fnins.2021.732611","volume":"15","author":"A De Giacomo","year":"2021","unstructured":"De Giacomo A, Gargano CD, Simone M, Petruzzelli MG, Pedaci C, Giambersio D, Margari L, Ruggieri M. B and T immunoregulation: A new insight of B regulatory lymphocytes in autism spectrum disorder. FRONT NEUROSCI-SWITZ. 2021;15:732611.","journal-title":"FRONT NEUROSCI-SWITZ"},{"issue":"5","key":"7389_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/aur.1570","volume":"9","author":"MW Nestor","year":"2016","unstructured":"Nestor MW, Phillips AW, Artimovich E, Nestor JE, Hussman JP, Blatt GJ. Human inducible pluripotent stem cells and autism spectrum disorder: emerging technologies. AUTISM RES. 2016;9(5):513\u201335.","journal-title":"AUTISM RES"},{"issue":"3","key":"7389_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/aur.1906","volume":"11","author":"IR Melamed","year":"2018","unstructured":"Melamed IR, Heffron M, Testori A, Lipe K. A pilot study of high-dose intravenous Immunoglobulin 5% for autism: impact on autism spectrum and markers of neuroinflammation. AUTISM RES. 2018;11(3):421\u201333.","journal-title":"AUTISM RES"},{"key":"7389_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2021.11.017","volume":"100","author":"DT Chen","year":"2022","unstructured":"Chen DT, Chang JP, Cheng SW, Chang HC, Hsu JH, Chang HH, Chiu WC, Su KP. Kawasaki disease in childhood and psychiatric disorders: A population-based case-control prospective study in Taiwan. BRAIN BEHAV IMMUN. 2022;100:105\u201311.","journal-title":"BRAIN BEHAV IMMUN"},{"issue":"2","key":"7389_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","volume":"33","author":"TR Malek","year":"2010","unstructured":"Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 2010;33(2):153\u201365.","journal-title":"Immunity"},{"key":"7389_CR11","doi-asserted-by":"crossref","unstructured":"Abbas AK, Trotta E, Marson RSD, Bluestone A. JA: Revisiting IL-2: biology and therapeutic prospects. SCI IMMUNOL. 2018, 3(25):eaat1482.","DOI":"10.1126\/sciimmunol.aat1482"},{"key":"7389_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","volume":"38","author":"PA Savage","year":"2020","unstructured":"Savage PA, Klawon D, Miller CH. Regulatory T cell development. ANNU REV IMMUNOL. 2020;38:421\u201353.","journal-title":"ANNU REV IMMUNOL"},{"issue":"2","key":"7389_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy S, Rudensky AY. Principles of regulatory T cell function. Immunity. 2023;56(2):240\u201355.","journal-title":"Immunity"},{"issue":"5","key":"7389_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","volume":"15","author":"D Klatzmann","year":"2015","unstructured":"Klatzmann D, Abbas AK. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. NAT REV IMMUNOL. 2015;15(5):283\u201394.","journal-title":"NAT REV IMMUNOL"},{"key":"7389_CR15","doi-asserted-by":"publisher","first-page":"648408","DOI":"10.3389\/fimmu.2021.648408","volume":"12","author":"H Gra\u00dfhoff","year":"2021","unstructured":"Gra\u00dfhoff H, Comd\u00fchr S, Monne LR, M\u00fcller A, Lamprecht P, Riemekasten G, Humrich JY. Low-Dose IL-2 therapy in autoimmune and rheumatic diseases. FRONT IMMUNOL. 2021;12:648408.","journal-title":"FRONT IMMUNOL"},{"issue":"9","key":"7389_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, Jin Y, Gan Y, Hu X, Jia R, et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. NAT MED. 2016;22(9):991\u20133.","journal-title":"NAT MED"},{"issue":"1","key":"7389_CR17","first-page":"2","volume":"15","author":"J Collison","year":"2019","unstructured":"Collison J. Low-dose IL-2 therapy for autoimmune diseases. NAT REV RHEUMATOL. 2019;15(1):2.","journal-title":"NAT REV RHEUMATOL"},{"issue":"5","key":"7389_CR18","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1007\/s11064-022-03527-x","volume":"47","author":"K Roe","year":"2022","unstructured":"Roe K. Autism spectrum disorder initiation by Inflammation-Facilitated neurotoxin transport. NEUROCHEM RES. 2022;47(5):1150\u201365.","journal-title":"NEUROCHEM RES"},{"key":"7389_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.neubiorev.2015.05.004","volume":"55","author":"S Wu","year":"2015","unstructured":"Wu S, Ding Y, Wu F, Li R, Xie G, Hou J, Mao P. Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis. NEUROSCI BIOBEHAV R. 2015;55:322\u201332.","journal-title":"NEUROSCI BIOBEHAV R"},{"issue":"1","key":"7389_CR20","doi-asserted-by":"publisher","first-page":"22587","DOI":"10.1038\/s41598-023-49902-8","volume":"13","author":"U Than","year":"2023","unstructured":"Than U, Nguyen LT, Nguyen PH, Nguyen XH, Trinh DP, Hoang DH, Nguyen P, Dang VD. Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy. SCI REP-UK. 2023;13(1):22587.","journal-title":"SCI REP-UK"},{"key":"7389_CR21","doi-asserted-by":"publisher","first-page":"102085","DOI":"10.1016\/j.rasd.2022.102085","volume":"101","author":"Z Nie","year":"2023","unstructured":"Nie Z, Han D, Zhang K, Li M, Kwon H, Im S, Xu L, Yang J, Li Z, Huang X, et al. TH1\/Treg ratio May be a marker of autism in children with immune dysfunction. RES AUTISM SPECT DIS. 2023;101:102085.","journal-title":"RES AUTISM SPECT DIS"},{"issue":"1","key":"7389_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41398-018-0214-7","volume":"8","author":"K Connery","year":"2018","unstructured":"Connery K, Tippett M, Delhey LM, Rose S, Slattery JC, Kahler SG, Hahn J, Kruger U, Cunningham MW, Shimasaki C, et al. Intravenous Immunoglobulin for the treatment of autoimmune encephalopathy in children with autism. TRANSL PSYCHIAT. 2018;8(1):148.","journal-title":"TRANSL PSYCHIAT"},{"issue":"1","key":"7389_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12015-021-10257-0","volume":"18","author":"L Villarreal-Mart\u00ednez","year":"2022","unstructured":"Villarreal-Mart\u00ednez L, Gonz\u00e1lez-Mart\u00ednez G, S\u00e1enz-Flores M, Bautista-G\u00f3mez AJ, Gonz\u00e1lez-Mart\u00ednez A, Ortiz-Castillo M, Robles-S\u00e1enz DA, Garza-L\u00f3pez E. Stem cell therapy in the treatment of patients with autism spectrum disorder: a systematic review and Meta-analysis. STEM CELL REV REP. 2022;18(1):155\u201364.","journal-title":"STEM CELL REV REP"},{"issue":"3","key":"7389_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08830185.2023.2274574","volume":"43","author":"R Zhang","year":"2024","unstructured":"Zhang R, Zhao Y, Chen X, Zhuang Z, Li X, Shen E. Low-dose IL-2 therapy in autoimmune diseases: an update review. INT REV IMMUNOL. 2024;43(3):113\u201337.","journal-title":"INT REV IMMUNOL"},{"issue":"1","key":"7389_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. ANN RHEUM DIS. 2020;79(1):141\u20139.","journal-title":"ANN RHEUM DIS"},{"issue":"1","key":"7389_CR26","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1038\/s41467-022-34162-3","volume":"13","author":"JY Zhang","year":"2022","unstructured":"Zhang JY, Hamey F, Trzupek D, Mickunas M, Lee M, Godfrey L, Yang J, Pekalski ML, Kennet J, Waldron-Lynch F, et al. Low-dose IL-2 reduces IL-21(+) T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. NAT COMMUN. 2022;13(1):7324.","journal-title":"NAT COMMUN"},{"issue":"12","key":"7389_CR27","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","volume":"77","author":"M Miao","year":"2018","unstructured":"Miao M, Hao Z, Guo Y, Zhang X, Zhang S, Luo J, Zhao X, Zhang C, Liu X, Wu X, et al. Short-term and low-dose IL-2 therapy restores the Th17\/Treg balance in the peripheral blood of patients with primary sj\u00f6gren\u2019s syndrome. ANN RHEUM DIS. 2018;77(12):1838\u201340.","journal-title":"ANN RHEUM DIS"},{"key":"7389_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbi.2024.02.019","volume":"118","author":"S Poletti","year":"2024","unstructured":"Poletti S, Zanardi R, Mandelli A, Aggio V, Finardi A, Lorenzi C, Borsellino G, Carminati M, Manfredi E, Tomasi E, et al. Low-dose Interleukin 2 antidepressant potentiation in unipolar and bipolar depression: safety, efficacy, and immunological biomarkers. BRAIN BEHAV IMMUN. 2024;118:52\u201368.","journal-title":"BRAIN BEHAV IMMUN"},{"issue":"1\u20132","key":"7389_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","volume":"207","author":"X Li","year":"2009","unstructured":"Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M. Elevated immune response in the brain of autistic patients. J NEUROIMMUNOL. 2009;207(1\u20132):111\u20136.","journal-title":"J NEUROIMMUNOL"},{"key":"7389_CR30","doi-asserted-by":"publisher","first-page":"778325","DOI":"10.3389\/fpsyt.2021.778325","volume":"12","author":"U Hyl\u00e9n","year":"2021","unstructured":"Hyl\u00e9n U, McGlinchey A, Ore\u0161i\u010d M, Bejerot S, Humble MB, S\u00e4rndahl E, Hy\u00f6tyl\u00e4inen T, Eklund D. Potential transdiagnostic lipid mediators of inflammatory activity in individuals with serious mental illness. FRONT PSYCHIATRY. 2021;12:778325.","journal-title":"FRONT PSYCHIATRY"},{"key":"7389_CR31","doi-asserted-by":"crossref","unstructured":"Siniscalco D, Schultz S, Brigida AL, Antonucci N. Inflammation and Neuro-Immune dysregulations in autism spectrum disorders. PHARMACEUTICALS-BASE 2018, 11(2): 56.","DOI":"10.3390\/ph11020056"},{"key":"7389_CR32","doi-asserted-by":"crossref","unstructured":"Ferencova N, Visnovcova Z, Ondrejka I, Hrtanek I, Bujnakova I, Kovacova V, Macejova A, Tonhajzerova I. Peripheral inflammatory markers in autism spectrum disorder and attention deficit\/hyperactivity disorder at adolescent age. INT J MOL SCI 2023, 24(14) : 11710.","DOI":"10.3390\/ijms241411710"},{"issue":"5","key":"7389_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/aur.3143","volume":"17","author":"F Capiotto","year":"2024","unstructured":"Capiotto F, Romano CG, Mirlisenna I, Mazza A, Cicinelli G, Lauritano C, Keller R. Dal Monte O: autonomic and hedonic response to affective touch in autism spectrum disorder. AUTISM RES. 2024;17(5):923\u201333.","journal-title":"AUTISM RES"},{"issue":"2","key":"7389_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jcpp.12147","volume":"55","author":"CJ Cascio","year":"2014","unstructured":"Cascio CJ, Foss-Feig JH, Heacock J, Schauder KB, Loring WA, Rogers BP, Pryweller JR, Newsom CR, Cockhren J, Cao A, et al. Affective neural response to restricted interests in autism spectrum disorders. J CHILD PSYCHOL PSYC. 2014;55(2):162\u201371.","journal-title":"J CHILD PSYCHOL PSYC"},{"issue":"3","key":"7389_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11011-015-9784-8","volume":"31","author":"GA Mostafa","year":"2016","unstructured":"Mostafa GA, Bj\u00f8rklund G, Urbina MA, Al-Ayadhi LY. The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder. METAB BRAIN DIS. 2016;31(3):593\u20139.","journal-title":"METAB BRAIN DIS"},{"issue":"6","key":"7389_CR36","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s10803-021-05150-1","volume":"52","author":"CM Harkins","year":"2022","unstructured":"Harkins CM, Handen BL, Mazurek MO. The impact of the comorbidity of ASD and ADHD on social impairment. J AUTISM DEV DISORD. 2022;52(6):2512\u201322.","journal-title":"J AUTISM DEV DISORD"},{"key":"7389_CR37","doi-asserted-by":"crossref","unstructured":"Wu YT, Tsao CH, Huang HC, Yang TA, Li YJ. Relationship between motor skills and Language abilities in children with autism spectrum disorder. PHYS THERAPY . 2021, 101(5) :pzab033.","DOI":"10.1093\/ptj\/pzab033"},{"issue":"1","key":"7389_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0165-5728(98)00021-6","volume":"85","author":"S Gupta","year":"1998","unstructured":"Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1- and Th2-like cytokines in CD4\u2009+\u2009and CD8\u2009+\u2009T cells in autism. J NEUROIMMUNOL. 1998;85(1):106\u20139.","journal-title":"J NEUROIMMUNOL"},{"issue":"1","key":"7389_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-017-0888-4","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Yazdani U, Gadad B, Zaman S, Hynan LS, Roatch N, Schutte C, Marti CN, Hewitson L, German DC. Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder. J NEUROINFLAMM. 2017;14(1):113.","journal-title":"J NEUROINFLAMM"},{"issue":"3","key":"7389_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41390-020-0910-x","volume":"89","author":"Y Shen","year":"2021","unstructured":"Shen Y, Li Y, Shi L, Liu M, Wu R, Xia K, Zhang F, Ou J, Zhao J. Autism spectrum disorder and severe social impairment associated with elevated plasma interleukin-8. PEDIATR RES. 2021;89(3):591\u20137.","journal-title":"PEDIATR RES"},{"key":"7389_CR41","doi-asserted-by":"crossref","unstructured":"Lee GR. The balance of Th17 versus Treg cells in autoimmunity. INT J MOL SCI . 2018, 19(3) :730.","DOI":"10.3390\/ijms19030730"},{"key":"7389_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","volume":"108","author":"HK Hughes","year":"2023","unstructured":"Hughes HK, R JM, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). BRAIN BEHAV IMMUN. 2023;108:245\u201354.","journal-title":"BRAIN BEHAV IMMUN"},{"key":"7389_CR43","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.neubiorev.2021.10.046","volume":"132","author":"B Yousefi","year":"2022","unstructured":"Yousefi B, Kokhaei P, Mehranfar F, Bahar A, Abdolshahi A, Emadi A, Eslami M. The role of the host Microbiome in autism and neurodegenerative disorders and effect of epigenetic procedures in the brain functions. NEUROSCI BIOBEHAV R. 2022;132:998\u20131009.","journal-title":"NEUROSCI BIOBEHAV R"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07389-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07389-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:26:01Z","timestamp":1760523961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07389-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7389"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07389-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"7 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, conducted at the Second Affiliated Hospital of Kunming Medical University (ID: 2020ynlc001), received ethical approval from the Medical Ethics Committee of the Second Affiliated Hospital of Kunming Medical University (Approval ID: Review-PJ-2020-102) on November 9 2020, in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants and their families. The study was registered as a clinical trial with the Chinese Clinical Trial Registry (ChiCTR ID: ChiCTR2000040836) on December 11, 2020, accessible via the ChiCTR website ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Given that the case reports involve underage children, written informed consent was obtained from the parents or legal guardians of each patient for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"991"}}